Clinical Report: Distinguishing Catatonia-like Symptoms from Catatonia

Overview

This case study highlights the diagnostic challenges in distinguishing catatonia from catatonia-like symptoms in a patient with schizophrenia and Guillain–Barré syndrome. The findings emphasize the importance of thorough clinical assessment to avoid misdiagnosis and ensure appropriate treatment.

Background

Catatonia is a significant neuropsychiatric syndrome that can complicate the management of psychiatric disorders, particularly schizophrenia. The overlap of catatonia with medical conditions like Guillain–Barré syndrome can lead to diagnostic confusion, potentially resulting in delayed treatment. Understanding the clinical features and implications of both conditions is crucial for effective patient care.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

• A 28-year-old man with schizophrenia presented with catatonia-like symptoms due to Guillain–Barré syndrome.
• Initial symptoms included hallucinations and delusions, which progressed to mutism and immobility.
• Diagnosis of Guillain–Barré syndrome was confirmed through cerebrospinal fluid analysis showing albuminocytologic dissociation.
• The patient was treated with intravenous immunoglobulin and continued on risperidone for schizophrenia management.
• After treatment, the patient showed significant improvement and returned to normal daily activities.
• This case underscores the need for careful differential diagnosis in patients with psychiatric histories presenting with acute neurological symptoms.

Clinical Implications

Clinicians should maintain a high index of suspicion for underlying medical conditions like Guillain–Barré syndrome in patients with psychiatric disorders presenting with catatonia-like symptoms. A thorough neurologic examination and timely investigations are essential to avoid misdiagnosis and ensure appropriate treatment.

Conclusion

This case illustrates the critical importance of distinguishing between primary psychiatric symptoms and those arising from medical conditions. Enhanced awareness and diagnostic vigilance can improve patient outcomes in complex cases.

References

1. BMC Psychiatry (Springer), 2025 -- Successful treatment of five cases of catatonia treated with guanfacine without ECT: a case series from a psychiatric hospital in Japan
2. Frontiers in Psychiatry, 2026 -- SARS-CoV-2 and Catatonia Syndrome: Investigating Its Existence Through Longitudinal Evidence
3. BMC Psychiatry (Springer), 2025 -- CATATOnia treatment with transcranial direct current electrostimulation: protocol of a randomised, double-blind, placebo-controlled bicentric superiority study (CATATOES)
4. BMC Psychiatry (Springer), 2025 -- Insights into Catatonia with and without Delirium in a Lebanese Tertiary Care Setting: A Retrospective Analysis of 36 Cases on the Consultation-Liaison Psychiatry Service
5. APA Resource Document, 2025 -- Resource Document on Catatonia
6. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome - PubMed, 2023
7. Catatonia and Delirium in a General Medical Setting: Prevalence and Naturalistic Treatment Outcome - ScienceDirect
8. APA Resource DocumentResource Document on CatatoniaApproved by the Joint Reference Committee, February 2025© Copyright 2025, American Psychiatric Association. All rights, including for text and data mining (TDM), Artificial Intelligence
9. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome - PubMed
10. Catatonia and Delirium in a General Medical Setting: Prevalence and Naturalistic Treatment Outcome - ScienceDirect